One Wealth Advisors, LLC Innoviva, Inc. Transaction History

One Wealth Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$11.61 - $15.22 $696 - $913	-60 Reduced 0.26%	22,734 $264,000
Q2 2022 Aug 15, 2022	SELL	$14.32 - $19.88 $7,747 - $10,755	-541 Reduced 2.32%	22,794 $336,000
Q1 2022 May 16, 2022	SELL	$15.39 - $20.25 $4,617 - $6,075	-300 Reduced 1.27%	23,335 $452,000
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $82,668 - $97,269	5,196 Added 28.18%	23,635 $408,000
Q3 2021 Nov 15, 2021	BUY	$13.06 - $17.24 $5,511 - $7,275	422 Added 2.34%	18,439 $308,000
Q1 2021 May 17, 2021	BUY	$11.06 - $12.87 $199,268 - $231,878	18,017 New	18,017 $215,000
Q4 2020 Feb 16, 2021	SELL	$9.33 - $12.48 $98,925 - $132,325	-10,603 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.33 - $14.49 $109,528 - $153,637	10,603 New	10,603 $111,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of One Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on One Wealth Advisors, LLC with notifications on news.